Literature DB >> 3767224

Malleus grip prosthesis.

H F Schuknecht, M L Bartley.   

Abstract

The malleus grip prosthesis is designed for ears with conductive hearing loss caused by pathologic conditions of the stapes in association with pathologic conditions of the malleus or incus. The malleus grip procedure was performed on 220 ears, and follow-up studies are available on 203. Mild to profound sensorineural hearing losses occurred in 16 (8.37%). The remaining 187, on the first postoperative test, had an average air-bone gap of 14 dB, and subsequent examinations on 100 of them showed no significant change with the passage of time. The procedure is technically more difficult than stapes surgery for otosclerosis, and success is highly dependent upon selection of appropriate cases and meticulous implantation of the prosthesis.

Entities:  

Mesh:

Year:  1986        PMID: 3767224     DOI: 10.1177/000348948609500517

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  4 in total

1.  Vascularization of the long process of the malleus: surgical implications.

Authors:  L A Vallejo-Valdezate; D Herrero-Calvo; M Garrosa-García
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-09-24       Impact factor: 2.503

2.  Results after revision stapedectomy with malleus grip prosthesis.

Authors:  Sarp Sarac; Michael J McKenna; Anthony A Mikulec; Steven D Rauch; Joseph B Nadol; Saumil N Merchant
Journal:  Ann Otol Rhinol Laryngol       Date:  2006-04       Impact factor: 1.547

3.  Delaying partial stapedectomy for otosclerosis: effects on long-term hearing outcomes following surgery.

Authors:  Anastasios Maniakas; Jade Nehme; Jean-Jacques Dufour; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-08       Impact factor: 2.503

4.  Malleostapedotomy with the self-fixing and articulated titanium piston.

Authors:  J Burggraaf; E A M Mylanus; R J E Pennings; Cor Cremers
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-19       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.